Table I.
Relationship between the clinicopathological parameters and miR-1 expression in primary CRC cases (N=111).
Expression of miR-1a | ||||
---|---|---|---|---|
Characteristics | No. of cases | Mean | 95% CI | P-value |
Age (years) | ||||
<60 | 48 | −2.441 | −3.42–1.65 | 0.076 |
≥60 | 63 | −0.903 | ||
Sex | ||||
Male | 45 | −1.303 | −1.09–2.39 | 0.458 |
Female | 66 | −1.956 | ||
Tumor size (cm) | ||||
<5 | 78 | −2.594 | −5.21–1.70 | 0.001 |
≥5 | 33 | 0.858 | ||
Differentiation | ||||
Well + moderate | 33 | 0.094 | 0.55–4.18 | 0.011 |
Poor | 78 | −2.271 | ||
Lymph node status | ||||
Negative | 63 | −3.082 | −5.01–1.91 | 0.001 |
Positive | 48 | 0.419 | ||
Metastasis | ||||
Negative | 95 | −1.543 | −2.26–2.61 | 0.888 |
Positive | 16 | −1.717 | ||
TNM stage | ||||
I + II | 55 | −3.122 | −4.69–1.47 | 0.001 |
III + IV | 56 | −0.042 |
Mean of the relative expression of miR-1 is expressed as log2 (fold change) value and 95% confidence interval (CI). CRC, colorectal cancer; microRNA-1, miR-1.